Sign In
Buy PGNY
$26.28
+0.200 (+0.767%)
At Close: Jun 22, 2026
Why Progyny Stock Dropped Today
01:48pm, Wednesday, 07'th Aug 2024
Progyny missed analysts' revenue expectations for the second quarter by a tiny margin. Making matters worse, the company cut sales growth guidance from 15% to 8.5% for 2024.
Progyny, Inc. (PGNY) Q2 2024 Earnings Call Transcript
10:35pm, Tuesday, 06'th Aug 2024
Progyny, Inc. (PGNY) Q2 2024 Earnings Call Transcript
Progyny (PGNY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
09:05pm, Tuesday, 06'th Aug 2024
Although the revenue and EPS for Progyny (PGNY) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street e
Progyny (PGNY) Beats Q2 Earnings Estimates
06:37pm, Tuesday, 06'th Aug 2024
Progyny (PGNY) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.15 per share a year ago.
Progyny, Inc. Announces Second Quarter 2024 Results
04:02pm, Tuesday, 06'th Aug 2024
Achieves Record Quarterly Adjusted EBITDA, Strong Cash Flow Conversion RateBoard Authorizes Repurchase of $100 Million of Common Stock
Progyny (PGNY) Reports Next Week: Wall Street Expects Earnings Growth
11:06am, Tuesday, 30'th Jul 2024
Progyny (PGNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dublin, July 12, 2024 (GLOBE NEWSWIRE) -- The "Assisted Reproductive Technology Global Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering. The glob
Progyny, Inc. to Host 2024 Inaugural Investor Day
01:42pm, Wednesday, 26'th Jun 2024
NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that it will host its inaug
Progyny, Inc. Announces Enhanced Global Services with Acquisition of Apryl
07:00am, Monday, 24'th Jun 2024
NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced an expansion of its global
Fertility Pioneer and Kindbody Founder Gina Bartasi Returns as CEO to Lead Company's Next Phase of Growth
11:00am, Tuesday, 11'th Jun 2024
Kindbody is the Largest Women-founded, Women-led Fertility Company Serving Employers and Families through its National Clinic Network and Proprietary Technology Platform NEW YORK, June 11, 2024 /PRNew
Progyny: At This Price, Secular Tailwinds Are Too Compelling To Ignore
03:22am, Monday, 10'th Jun 2024
Progyny finds itself in an industry enjoying numerous secular tailwinds that they are well-positioned to capitalize on. The company reported Q1'24 on the 9th of May, with the stock plummeting around 1
Progyny, Inc. to Present at Jefferies Global Healthcare Conference
03:00pm, Tuesday, 04'th Jun 2024
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny'
Progyny: No Change To Long-Term Outlook
10:01pm, Monday, 03'rd Jun 2024
PGNY experienced a revenue miss in 1Q24 due to weak utilization. Historical data shows that IVF demand has been resilient, with strong rebounds following economic downturns. Leading indicators suggest
Progyny's board approves another $100 million stock buyback
05:30pm, Wednesday, 22'nd May 2024
The board of Progyny PGNY, -2.62% has approved a $100 million share-repurchase authorization, its second this year.
Progyny, Inc. Announces Additional Share Repurchase Program
05:00pm, Wednesday, 22'nd May 2024
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, announced today that its Board of Directors
